PROM1

PROM1, also known as Prominin 1, is a protein coding gene that plays a crucial role in cell adhesion and migration. This protein is a type I integral membrane protein, which is often used as a marker for cancer stem cells. PROM1 is involved in various signaling pathways, including Wnt and Notch pathways, and is associated with diseases such as Macular Dystrophy and Cone-Rod Dystrophy. In terms of drug development, monoclonal antibodies targeting PROM1, like ICT-121 and COR-3, have shown promise in cancer therapy.
Recent advancements in drug development have focused on anti-CD133 monoclonal antibodies, which target PROM1. These therapies aim to inhibit the growth and spread of cancer cells by disrupting the signaling pathways that rely on PROM1. The ongoing research in this area holds potential for novel treatments for PROM1-related diseases.